Global Egg-Based Flu Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Egg-Based Flu Vaccines market size was valued at USD 7330.2 million in 2022 and is forecast to a readjusted size of USD 10170 million by 2029 with a CAGR of 4.8% during review period.
The most common way that flu vaccines are made is using an egg-based manufacturing process. that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the “flu shot”) and live attenuated (weakened virus) vaccine (usually called the “nasal spray flu vaccine”).
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
The Global Info Research report includes an overview of the development of the Egg-Based Flu Vaccines industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Egg-Based Flu Vaccines.
Regionally, the report analyzes the Egg-Based Flu Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Egg-Based Flu Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Egg-Based Flu Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Egg-Based Flu Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Egg-Based Flu Vaccines market.
Regional Analysis: The report involves examining the Egg-Based Flu Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Egg-Based Flu Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Egg-Based Flu Vaccines:
Company Analysis: Report covers individual Egg-Based Flu Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Egg-Based Flu Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Egg-Based Flu Vaccines. It assesses the current state, advancements, and potential future developments in Egg-Based Flu Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Egg-Based Flu Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Egg-Based Flu Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Egg-Based Flu Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Egg-Based Flu Vaccines, with price, sales, revenue and global market share of Egg-Based Flu Vaccines from 2018 to 2023.
Chapter 3, the Egg-Based Flu Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Egg-Based Flu Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Egg-Based Flu Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Egg-Based Flu Vaccines.
Chapter 14 and 15, to describe Egg-Based Flu Vaccines sales channel, distributors, customers, research findings and conclusion.
The most common way that flu vaccines are made is using an egg-based manufacturing process. that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the “flu shot”) and live attenuated (weakened virus) vaccine (usually called the “nasal spray flu vaccine”).
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
The Global Info Research report includes an overview of the development of the Egg-Based Flu Vaccines industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Egg-Based Flu Vaccines.
Regionally, the report analyzes the Egg-Based Flu Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Egg-Based Flu Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Egg-Based Flu Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Egg-Based Flu Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Egg-Based Flu Vaccines market.
Regional Analysis: The report involves examining the Egg-Based Flu Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Egg-Based Flu Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Egg-Based Flu Vaccines:
Company Analysis: Report covers individual Egg-Based Flu Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Egg-Based Flu Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Egg-Based Flu Vaccines. It assesses the current state, advancements, and potential future developments in Egg-Based Flu Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Egg-Based Flu Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Egg-Based Flu Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- 6 Months to 3 Years
- > 3 Years
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu GDK
- KM Biologics
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Egg-Based Flu Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Egg-Based Flu Vaccines, with price, sales, revenue and global market share of Egg-Based Flu Vaccines from 2018 to 2023.
Chapter 3, the Egg-Based Flu Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Egg-Based Flu Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Egg-Based Flu Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Egg-Based Flu Vaccines.
Chapter 14 and 15, to describe Egg-Based Flu Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Egg-Based Flu Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Egg-Based Flu Vaccines Market Size & Forecast
1.5.1 Global Egg-Based Flu Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Egg-Based Flu Vaccines Sales Quantity (2018-2029)
1.5.3 Global Egg-Based Flu Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Egg-Based Flu Vaccines Product and Services
2.1.4 Sanofi Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Egg-Based Flu Vaccines Product and Services
2.2.4 CSL Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Egg-Based Flu Vaccines Product and Services
2.3.4 GSK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Egg-Based Flu Vaccines Product and Services
2.4.4 Viatris Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Egg-Based Flu Vaccines Product and Services
2.5.4 AstraZeneca Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Egg-Based Flu Vaccines Product and Services
2.6.4 Hualan Bio Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
2.7.4 Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Egg-Based Flu Vaccines Product and Services
2.8.4 Sinovac Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments/Updates
2.9 BCHT
2.9.1 BCHT Details
2.9.2 BCHT Major Business
2.9.3 BCHT Egg-Based Flu Vaccines Product and Services
2.9.4 BCHT Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BCHT Recent Developments/Updates
2.10 Jiangsu GDK
2.10.1 Jiangsu GDK Details
2.10.2 Jiangsu GDK Major Business
2.10.3 Jiangsu GDK Egg-Based Flu Vaccines Product and Services
2.10.4 Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu GDK Recent Developments/Updates
2.11 KM Biologics
2.11.1 KM Biologics Details
2.11.2 KM Biologics Major Business
2.11.3 KM Biologics Egg-Based Flu Vaccines Product and Services
2.11.4 KM Biologics Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EGG-BASED FLU VACCINES BY MANUFACTURER
3.1 Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
3.5 Egg-Based Flu Vaccines Market: Overall Company Footprint Analysis
3.5.1 Egg-Based Flu Vaccines Market: Region Footprint
3.5.2 Egg-Based Flu Vaccines Market: Company Product Type Footprint
3.5.3 Egg-Based Flu Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Egg-Based Flu Vaccines Market Size by Region
4.1.1 Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Egg-Based Flu Vaccines Average Price by Region (2018-2029)
4.2 North America Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.3 Europe Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.5 South America Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Egg-Based Flu Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2029)
5.3 Global Egg-Based Flu Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2029)
6.3 Global Egg-Based Flu Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Egg-Based Flu Vaccines Market Size by Country
7.3.1 North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Egg-Based Flu Vaccines Market Size by Country
8.3.1 Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Egg-Based Flu Vaccines Market Size by Region
9.3.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Egg-Based Flu Vaccines Market Size by Country
10.3.1 South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Egg-Based Flu Vaccines Market Size by Country
11.3.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Egg-Based Flu Vaccines Market Drivers
12.2 Egg-Based Flu Vaccines Market Restraints
12.3 Egg-Based Flu Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Egg-Based Flu Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Egg-Based Flu Vaccines
13.3 Egg-Based Flu Vaccines Production Process
13.4 Egg-Based Flu Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Egg-Based Flu Vaccines Typical Distributors
14.3 Egg-Based Flu Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Egg-Based Flu Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Egg-Based Flu Vaccines Market Size & Forecast
1.5.1 Global Egg-Based Flu Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Egg-Based Flu Vaccines Sales Quantity (2018-2029)
1.5.3 Global Egg-Based Flu Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Egg-Based Flu Vaccines Product and Services
2.1.4 Sanofi Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Egg-Based Flu Vaccines Product and Services
2.2.4 CSL Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Egg-Based Flu Vaccines Product and Services
2.3.4 GSK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Egg-Based Flu Vaccines Product and Services
2.4.4 Viatris Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Egg-Based Flu Vaccines Product and Services
2.5.4 AstraZeneca Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Egg-Based Flu Vaccines Product and Services
2.6.4 Hualan Bio Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
2.7.4 Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Egg-Based Flu Vaccines Product and Services
2.8.4 Sinovac Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments/Updates
2.9 BCHT
2.9.1 BCHT Details
2.9.2 BCHT Major Business
2.9.3 BCHT Egg-Based Flu Vaccines Product and Services
2.9.4 BCHT Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BCHT Recent Developments/Updates
2.10 Jiangsu GDK
2.10.1 Jiangsu GDK Details
2.10.2 Jiangsu GDK Major Business
2.10.3 Jiangsu GDK Egg-Based Flu Vaccines Product and Services
2.10.4 Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu GDK Recent Developments/Updates
2.11 KM Biologics
2.11.1 KM Biologics Details
2.11.2 KM Biologics Major Business
2.11.3 KM Biologics Egg-Based Flu Vaccines Product and Services
2.11.4 KM Biologics Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EGG-BASED FLU VACCINES BY MANUFACTURER
3.1 Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
3.5 Egg-Based Flu Vaccines Market: Overall Company Footprint Analysis
3.5.1 Egg-Based Flu Vaccines Market: Region Footprint
3.5.2 Egg-Based Flu Vaccines Market: Company Product Type Footprint
3.5.3 Egg-Based Flu Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Egg-Based Flu Vaccines Market Size by Region
4.1.1 Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Egg-Based Flu Vaccines Average Price by Region (2018-2029)
4.2 North America Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.3 Europe Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.5 South America Egg-Based Flu Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Egg-Based Flu Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2029)
5.3 Global Egg-Based Flu Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2029)
6.3 Global Egg-Based Flu Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Egg-Based Flu Vaccines Market Size by Country
7.3.1 North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Egg-Based Flu Vaccines Market Size by Country
8.3.1 Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Egg-Based Flu Vaccines Market Size by Region
9.3.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Egg-Based Flu Vaccines Market Size by Country
10.3.1 South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Egg-Based Flu Vaccines Market Size by Country
11.3.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Egg-Based Flu Vaccines Market Drivers
12.2 Egg-Based Flu Vaccines Market Restraints
12.3 Egg-Based Flu Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Egg-Based Flu Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Egg-Based Flu Vaccines
13.3 Egg-Based Flu Vaccines Production Process
13.4 Egg-Based Flu Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Egg-Based Flu Vaccines Typical Distributors
14.3 Egg-Based Flu Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Egg-Based Flu Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Egg-Based Flu Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Egg-Based Flu Vaccines Product and Services
Table 6. Sanofi Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Egg-Based Flu Vaccines Product and Services
Table 11. CSL Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Egg-Based Flu Vaccines Product and Services
Table 16. GSK Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Egg-Based Flu Vaccines Product and Services
Table 21. Viatris Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Egg-Based Flu Vaccines Product and Services
Table 26. AstraZeneca Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Egg-Based Flu Vaccines Product and Services
Table 31. Hualan Bio Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
Table 36. Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Egg-Based Flu Vaccines Product and Services
Table 41. Sinovac Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Recent Developments/Updates
Table 43. BCHT Basic Information, Manufacturing Base and Competitors
Table 44. BCHT Major Business
Table 45. BCHT Egg-Based Flu Vaccines Product and Services
Table 46. BCHT Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BCHT Recent Developments/Updates
Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu GDK Major Business
Table 50. Jiangsu GDK Egg-Based Flu Vaccines Product and Services
Table 51. Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu GDK Recent Developments/Updates
Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 54. KM Biologics Major Business
Table 55. KM Biologics Egg-Based Flu Vaccines Product and Services
Table 56. KM Biologics Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. KM Biologics Recent Developments/Updates
Table 58. Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Egg-Based Flu Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Egg-Based Flu Vaccines Production Site of Key Manufacturer
Table 63. Egg-Based Flu Vaccines Market: Company Product Type Footprint
Table 64. Egg-Based Flu Vaccines Market: Company Product Application Footprint
Table 65. Egg-Based Flu Vaccines New Market Entrants and Barriers to Market Entry
Table 66. Egg-Based Flu Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Egg-Based Flu Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Egg-Based Flu Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Egg-Based Flu Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Egg-Based Flu Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Egg-Based Flu Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Egg-Based Flu Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Egg-Based Flu Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Egg-Based Flu Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Egg-Based Flu Vaccines Raw Material
Table 126. Key Manufacturers of Egg-Based Flu Vaccines Raw Materials
Table 127. Egg-Based Flu Vaccines Typical Distributors
Table 128. Egg-Based Flu Vaccines Typical Customers
Table 1. Global Egg-Based Flu Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Egg-Based Flu Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Egg-Based Flu Vaccines Product and Services
Table 6. Sanofi Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Egg-Based Flu Vaccines Product and Services
Table 11. CSL Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Egg-Based Flu Vaccines Product and Services
Table 16. GSK Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Egg-Based Flu Vaccines Product and Services
Table 21. Viatris Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Egg-Based Flu Vaccines Product and Services
Table 26. AstraZeneca Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Egg-Based Flu Vaccines Product and Services
Table 31. Hualan Bio Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
Table 36. Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Egg-Based Flu Vaccines Product and Services
Table 41. Sinovac Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Recent Developments/Updates
Table 43. BCHT Basic Information, Manufacturing Base and Competitors
Table 44. BCHT Major Business
Table 45. BCHT Egg-Based Flu Vaccines Product and Services
Table 46. BCHT Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BCHT Recent Developments/Updates
Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu GDK Major Business
Table 50. Jiangsu GDK Egg-Based Flu Vaccines Product and Services
Table 51. Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu GDK Recent Developments/Updates
Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 54. KM Biologics Major Business
Table 55. KM Biologics Egg-Based Flu Vaccines Product and Services
Table 56. KM Biologics Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. KM Biologics Recent Developments/Updates
Table 58. Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Egg-Based Flu Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Egg-Based Flu Vaccines Production Site of Key Manufacturer
Table 63. Egg-Based Flu Vaccines Market: Company Product Type Footprint
Table 64. Egg-Based Flu Vaccines Market: Company Product Application Footprint
Table 65. Egg-Based Flu Vaccines New Market Entrants and Barriers to Market Entry
Table 66. Egg-Based Flu Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Egg-Based Flu Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Egg-Based Flu Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Egg-Based Flu Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Egg-Based Flu Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Egg-Based Flu Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Egg-Based Flu Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Egg-Based Flu Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Egg-Based Flu Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Egg-Based Flu Vaccines Raw Material
Table 126. Key Manufacturers of Egg-Based Flu Vaccines Raw Materials
Table 127. Egg-Based Flu Vaccines Typical Distributors
Table 128. Egg-Based Flu Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Egg-Based Flu Vaccines Picture
Figure 2. Global Egg-Based Flu Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Egg-Based Flu Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Egg-Based Flu Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Egg-Based Flu Vaccines Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Egg-Based Flu Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Egg-Based Flu Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Egg-Based Flu Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Egg-Based Flu Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Egg-Based Flu Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Egg-Based Flu Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Egg-Based Flu Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Egg-Based Flu Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Egg-Based Flu Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Egg-Based Flu Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Egg-Based Flu Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egg-Based Flu Vaccines Market Drivers
Figure 73. Egg-Based Flu Vaccines Market Restraints
Figure 74. Egg-Based Flu Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Egg-Based Flu Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Egg-Based Flu Vaccines
Figure 78. Egg-Based Flu Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Egg-Based Flu Vaccines Picture
Figure 2. Global Egg-Based Flu Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Egg-Based Flu Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Egg-Based Flu Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Egg-Based Flu Vaccines Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Egg-Based Flu Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Egg-Based Flu Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Egg-Based Flu Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Egg-Based Flu Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Egg-Based Flu Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Egg-Based Flu Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Egg-Based Flu Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Egg-Based Flu Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Egg-Based Flu Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Egg-Based Flu Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Egg-Based Flu Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egg-Based Flu Vaccines Market Drivers
Figure 73. Egg-Based Flu Vaccines Market Restraints
Figure 74. Egg-Based Flu Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Egg-Based Flu Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Egg-Based Flu Vaccines
Figure 78. Egg-Based Flu Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
